Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants.
暂无分享,去创建一个
F M Waterman | Y. Yu | F. Waterman | Y Yu | A Schulsinger | N Suntharalingam | N. Suntharalingam | A. Schulsinger
[1] L L Anderson,et al. A nomograph for permanent implants of palladium-103 seeds. , 1993, International journal of radiation oncology, biology, physics.
[2] J. Roy,et al. CT-based optimized planning for transperineal prostate implant with customized template. , 1991, International journal of radiation oncology, biology, physics.
[3] H. Holm,et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.
[4] J. Roy,et al. Quantifying the effect of dose inhomogeneity in brachytherapy: application to permanent prostatic implant with 125I seeds. , 1994, International journal of radiation oncology, biology, physics.
[5] C C Ling,et al. A CT-based evaluation method for permanent implants: application to prostate. , 1993, International journal of radiation oncology, biology, physics.
[6] L L Anderson,et al. Spacing nomograph for interstitial implants of 125I seeds. , 1976, Medical physics.
[7] F. Waterman,et al. Absorbed dose determination for interstitial 125I boost therapy. , 1983, Medical physics.
[8] C. Saw,et al. Quantitative assessment of interstitial implants. , 1991, International journal of radiation oncology, biology, physics.
[9] L. Anderson,et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .